solanezumab

What Explains the FDA’s Big Gamble on Aducanumab, the New Alzheimer’s Drug?

Alzheimer’s is Linked to Gum Disease – But Bad Oral Health is Not the Only Culprit

Lilly’s Drug for Alzheimer’s Fails Big Trial